Therapy

 

Find The Best Stocks With Perfect Trade Setups In Minutes A Day

Stop wasting time looking for the right stocks.  Free training on how to find perfect stock trades that can move 300-1,500%.  Learn the # 1 key to successful stock investing and how to find success even If the market is crashing, rebounding… or just going sideways. (ad)

Do Not Delay - Click Here Now

 

Biopharmaceuticals
Penny Stocks
Therapy
TradersPro Penny Stocks

Acorda Therapeutics, Inc. (ACOR)

Trade Setup Stocks found in this category are low priced stocks priced between .50 and $1, with at least 50k shares of average shares trading per day.   The stocks are pausing a trend either up or down, with a new bar over the prior day open or close.  These are high reward to risk stocks with the […]

Read More
Health
HeathCare
Penny Stocks
Therapy
TradersPro Penny Stocks

Dynatronics Corporation (DYNT)

Trade Setup Stocks found in this category are low priced stocks priced between .50 and $1, with at least 50k shares of average shares trading per day.   The stocks are pausing a trend either up or down, with a new bar over the prior day open or close.  These are high reward to risk stocks with the […]

Read More
Health
Penny Stocks
Therapy
TradersPro Penny Stocks

Bionano Genomics, Inc. (BNGO)

Trade Setup Stocks found in this category are low priced stocks priced between .50 and $1, with at least 50k shares of average shares trading per day.   The stocks are pausing a trend either up or down, with a new bar over the prior day open or close.  These are high reward to risk stocks with the […]

Read More
Biotech
Health
HeathCare
Therapy
TradersPro Alerts

Vaccinex, Inc. (VCNX) Buy Target $4.31 Sell Target $5.36

Trade Setup Buy Target $4.31 Sell Target $5.36 Vaccinex, Inc., a clinical-stage biotechnology company, discovers and develops bio therapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab that is in clinical development […]

Read More
Health
HeathCare
Therapy
TradersPro Alerts

Amarin Corporation plc (AMRN) Buy Target $9.65 Sell Target $13.18

Trade Setup Buy Target $9.65 Sell Target $13.18 Amarin Corporation plc, a pharmaceutical company, develops and commercializes therapeutics for the treatment of cardiovascular diseases in the United States. The company’s lead product is Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe […]

Read More
Biotech
Therapy
TradersPro Alerts

Lineage Cell Therapeutics, Inc. (LCTX) Buy Target $1.00 Sell Target $1.25

Trade Setup Buy Target $1.00 Sell Target $1.25 Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing therapies for the treatment of degenerative diseases in the United States and internationally. The company’s lead product candidates include OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa multicenter trial […]

Read More
Health
HeathCare
Therapy
TradersPro Alerts

ImmunoGen, Inc. (IMGN) Buy Target $3.91 Sell Target $5.11

Trade Setup Buy Target $3.91 Sell Target $5.11 ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. Its product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha, which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer.

Read More
Health
HeathCare
Therapy
TradersPro Alerts

Trillium Therapeutics Inc. (TRIL) Buy Target $4.59 Sell Target $5.88

Trade Setup Buy Target $4.59 Sell Target $5.88 Trillium Therapeutics Inc., a clinical-stage immuno-oncology company, develops therapies for the treatment of cancer. The company’s lead program is TTI-621, a SIRPaFc fusion protein that acts a soluble decoy receptor preventing CD47 from delivering its inhibitory signal, which is in Phase Ib clinical trials for advanced hematologic […]

Read More
Health
HeathCare
Therapy
TradersPro Alerts

Karyopharm Therapeutics Inc. (KPTI) Buy Target $19.59 Sell Target $23.41

Trade Setup Buy Target $19.59 Sell Target $23.41 Karyopharm Therapeutics Inc., an oncology-focused pharmaceutical company, engages in the discovery, development, and commercialization of various drugs directed against nuclear export and related targets for the treatment of cancer and other diseases. The company is developing small molecule selective inhibitor of nuclear export (SINE) compounds that inhibit […]

Read More
Health
HeathCare
Therapy
TradersPro Alerts

Can-Fite BioPharma Ltd. (CANF) Buy Target $2.22 Sell Target $2.92

Trade Setup Buy Target $2.22 Sell Target $2.92 Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver and inflammatory disease, and sexual dysfunction. The company’s lead drug candidate CF101 (Piclidenoson), which is in Phase III clinical trial for the treatment of rheumatoid arthritis and psoriasis.

Read More

There are risks inherent in all investments, which may make such investments unsuitable for certain persons. These include, for example, economic, political, currency exchange, rate fluctuations, and limited availability of information on international securities. You may lose all of your money trading and investing. Do NOT enter any trade without fully understanding the worst-case scenarios of that trade. And do NOT trade with money you cannot afford to lose. Past performance of an investment is not necessarily indicative of its future results. No assurance can be given that any implied recommendation will be profitable or will not be subject to losses. Information provided by the Company is not investment advice. The Company is not a registered investment adviser, stock broker, or brokerage. You agree that the Company does not represent, warrant, or take responsibility that any account will or is likely to achieve profit or losses similar to those shown. Examples published by the Company are selected for illustrative purposes only. They are not typical and do not represent the typical results of all stocks within the Companys software or its individual scans and searches. No independent party has audited any hypothetical performance contained at this Web site, nor has any independent party undertaken to confirm that they reflect the trading method under the assumptions or conditions specified.

FREE TRADING WEBINAR - TRADERSPRO PRESENTS: Starting With Only $10,000 Retire With $2.4 Million? Click Here Now

Join Us Now
X